Radix Polygalae Extract-Based Therapies for Novel Health Applications

This inventive concept leverages the core technology of Radix Polygalae extract to treat a range of novel health applications beyond attention-deficit hyperactivity disorder (ADHD), including chronic pain, fibromyalgia, irritable bowel syndrome, Alzheimer's disease, and post-traumatic stress disorder.

The original patent disclosed a method for treating ADHD using Radix Polygalae extract. However, the limitations of the original patent lie in its narrow focus on ADHD treatment. The present inventive concept addresses this limitation by exploring the application of Radix Polygalae extract in entirely new industries and fields, unlocking its potential to improve human health and quality of life.

The inventive concept involves administering Radix Polygalae extract-based compositions to subjects in need thereof for treating various health conditions. The extract's active compounds interact with the body's biochemical pathways to modulate pain perception, reduce inflammation, and improve cognitive function. Specifically, the new claims encompass systems and methods for improving sleep quality in patients with chronic pain, treating fibromyalgia, reducing anxiety in patients with irritable bowel syndrome, improving cognitive function in patients with Alzheimer's disease, and reducing symptoms of post-traumatic stress disorder.

The novelty of the present inventive concept lies in the unexpected application of Radix Polygalae extract to treat novel health applications beyond ADHD. The inventive step involves recognizing the extract's potential to address a broader range of health conditions, and developing compositions and methods tailored to these specific applications.

Alternative embodiments of the inventive concept may involve varying the formulation, dosage, and route of administration of the Radix Polygalae extract-based compositions. Additionally, the extract could be combined with other active compounds or excipients to enhance its therapeutic effects. Other variations may include developing topical or transdermal formulations for localized treatment of pain and inflammation.

The inventive concept has significant commercial potential in the pharmaceutical and healthcare industries, with potential applications in pain management, neurology, and psychiatry. The target market includes patients suffering from chronic pain, fibromyalgia, irritable bowel syndrome, Alzheimer's disease, and post-traumatic stress disorder, as well as healthcare providers seeking innovative therapeutic solutions.